文献速递生殖医学

医学辅助生殖实验室中的电子见证:使用10年后的见解与考量

Electronic witnessing in the medically assisted reproduction laboratory: insights and considerations after 10 years of use.
PubMed 文献 · Hum Reprod · 2023-01-01

该研究评估了2011年3月至2021年12月期间电子见证系统的错配率和管理员指派率,共纳入109655个周期。总体错配率为每见证点0.251%、每周期1.944%,其中关键错配144次;总体管理员指派率为每见证点0.111%、每周期0.857%,其中关键管理员指派320次。精子准备和IVF/ICSI是最易发生关键错配和管理员指派的程序。

要点

  • 正确使用时,电子见证系统可替代人工见证以防止样本混淆。
  • 总体错配率为每见证点0.251%(2132/849650),每周期1.944%。
  • 关键错配年均率为每见证点0.017±0.007%,每周期0.129±0.052%。

核心结论

  • 正确应用时,电子见证系统可替代医学辅助生殖实验室中的人工见证,以防止样本混淆。

研究设计与样本

  • 该评估研究调查了2011年3月至2021年12月期间使用电子见证系统的错配率和管理员指派率,采用射频识别标签和条形码进行患者和样本识别。
  • 自2011年起纳入IVF和ICSI周期及冻融胚胎移植周期,自2013年起纳入IUI周期。
  • 共纳入109655个周期:53023个IVF/ICSI周期、36347个FET周期和20285个IUI周期。

主要发现

  • 使用的724096个标签共产生849650个见证点。
  • 总体错配率为每见证点0.251%(2132/849650),每周期1.944%,不同程序中共发生144次关键错配。
  • 总体管理员指派率为每见证点0.111%(940/849650),每周期0.857%,包括320次关键管理员指派。
  • 关键错配年均率为每见证点0.017±0.007%,每周期0.129±0.052%;关键管理员指派年均率为每见证点0.039±0.010%,每周期0.301±0.069%。
  • 总体错配率和管理员指派率在研究期间保持相当稳定,精子准备和IVF/ICSI是最易发生关键错配和管理员指派的程序。

关键数值与推荐

  • 总体错配率:每见证点0.251%(2132/849650),每周期1.944%。
  • 总体管理员指派率:每见证点0.111%(940/849650),每周期0.857%。
  • 关键错配年均率:每见证点0.017±0.007%,每周期0.129±0.052%。
  • 关键管理员指派年均率:每见证点0.039±0.010%,每周期0.301±0.069%。

临床怎么用

  • 电子见证系统的整合程序和方法可能因实验室而异,导致样本识别相关潜在风险存在差异。
  • 单个胚胎尚不能被此类系统识别,因此在某些关键步骤中人工见证仍不可或缺。
  • 电子见证系统仍需与培养皿和管底部及盖子的手动标记结合使用,以确保在故障或射频识别标签使用不当时正确分配。
  • 作者认为电子见证被视为保障配子和胚胎正确识别的终极工具,但仅在正确使用时才能实现,需要工作人员适当培训和关注。
  • 作者认为电子见证也可能引入新风险,即操作者对样本的盲目见证。

局限性

  • 电子见证系统的整合程序和方法可能因实验室而异,导致样本识别相关潜在风险存在差异。
  • 单个胚胎尚不能被此类系统识别,这使得在某些潜在错误未被记录的关键步骤中额外的人工见证不可或缺。
  • 电子见证系统仍需与培养皿和管底部及盖子的手动标记结合使用,以确保在故障或射频识别标签使用不当时正确分配。
  • 作者认为电子见证也可能引入新风险,即操作者对样本的盲目见证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What have we learnt after 10 years of electronic witnessing? SUMMARY ANSWER: When applied correctly, an electronic witnessing system can replace manual witnessing in the medically assisted reproduction lab to prevent sample mix-up. WHAT IS KNOWN ALREADY: Electronic witnessing systems have been implemented to improve the correct identification, processing, and traceability of biological materials. When non-matching samples are simultaneously present in a single workstation, a mismatch event is generated to prevent sample mix-up. STUDY DESIGN, SIZE, DURATION: This evaluation investigates the mismatch and administrator assign rate over a 10-year period (March 2011-December 2021) with the use of an electronic witnessing system. Radiofrequency identification tags and barcodes were used for patient and sample identification. Since 2011, IVF and ICSI cycles and frozen embryo transfer cycles (FET) were included; IUIs cycles were included since 2013. PARTICIPANTS/MATERIALS, SETTING, METHODS: The total number of tags and witnessing points were recorded. Witnessing points in a particular electronic witnessing system represent all the actions that have been performed from gamete collection through embryo production, to cryopreservation and transfer. Mismatches and administrator assigns were collected and stratified per procedure (sperm preparation, oocyte retrieval, IVF/ICSI, cleavage stage embryo or blastocyst embryo biopsy, vitrification and warming, embryo transfer, medium changeover, and IUI). Critical mismatches (such as mislabelling or non-matching samples within one work area) and critical administrator assigns (such as samples not identified by the electronic witnessing system and unconfirmed witnessing points) were selected. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 109 655 cycles were included: 53 023 IVF/ICSI, 36 347 FET, and 20 285 IUI cycles. The 724 096 used tags, led to a total of 849 650 witnessing points. The overall mismatch rate was 0.251% (2132/849 650) per witnessing point and 1.944% per cycle. In total, 144 critical mismatches occurred over the different procedures. The yearly mean critical mismatch rate was 0.017 ± 0.007% per witnessing point and 0.129 ± 0.052% per cycle. The overall administrator assign rate was 0.111% (940/849 650) per witnessing point and 0.857% per cycle, including 320 critical administrator assigns. The yearly mean critical administrator assign rate was 0.039 ± 0.010% per witnessing point and 0.301 ± 0.069% per cycle. Overall mismatch and administrator assign rates remained fairly stable during the evaluated time period. Sperm preparation and IVF/ICSI were the procedures most prone to critical mismatch and administrator assigns. LIMITATIONS, REASONS FOR CAUTION: The procedures and methods of integration of an electronic witnessing system may vary from one laboratory to another and result in differences in the potential risks related to sample identification. Individual embryos cannot (yet) be identified by such a system; this makes extra manual witnessing indispensable at certain critical steps where potential errors are not recorded. The electronic witnessing system still needs to be used in combination with manual labelling of both the bottom and lid of dishes and tubes to guarantee correct assignment in case of malfunction or incorrect use of radiofrequency identification tags. WIDER IMPLICATIONS OF THE FINDINGS: Electronic witnessing is considered to be the ultimate tool to safeguard correct identification of gametes and embryos. But this is only possible when used correctly, and proper training and attention of the staff is required. It may also induce new risks, i.e. blind witnessing of samples by the operator. STUDY FUNDING/COMPETING INTEREST(S): No funding was either sought or obtained for this study. J.S. presents webinars on RIW for CooperSurgical. The remaining authors have nothing to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Sterckx J, Wouters K, Mateizel I, et al. Electronic witnessing in the medically assisted reproduction laboratory: insights and considerations after 10 years of use. Hum Reprod. 2023. PMID: 37295967. doi:10.1093/humrep/dead115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。